AI assistant
Sending…
CVS GROUP PLC — Regulatory Filings 2015
Jun 15, 2015
7590_rns_2015-06-15_2f6e914f-964e-4f9f-be10-e924e100085b.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8012P
CVS Group plc
15 June 2015
15 June 2015
CVS Group plc
(the "Company")
Block Listing Interim Review
CVS, the UK's leading provider of veterinary services, provides the following information in connection with its block admission pursuant to AIM Rule 29 and Schedule Six of the AIM Rules:
| Name of company: | CVS Group plc |
| Name of scheme: | 2011/2014 Save as You Earn Scheme |
| Period of return: | From: 15 December 2014 To: 15 June 2015 |
| Number and class of securities not issued under the scheme at the start of the period | 295,326 ordinary shares of 0.2p each |
| Number of securities issued under the scheme during the period | 280,805 ordinary shares of 0.2p each |
| Balance under the scheme of securities not yet issued at the end of the period | 14,521 ordinary shares of 0.2p each |
| Number and class of securities originally admitted and the date of admission | 295,326 ordinary shares of 0.2p each on 15 December 2014 |
| Name of contact: | Nick Perrin |
| Telephone number of contact: | 01379 644 288 |
Contacts:
| CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director |
Tel: 01379 644 288 |
| N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Alex Wright |
Tel: 020 7496 3000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRFMMJTMBTBBPA
More from CVS GROUP PLC
Regulatory Filings
2026
Jun 2
Transaction in Own Shares
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Director's Dealing
2026
May 28
Board/Management Information
2026
May 26
Transaction in Own Shares
2026
May 26
Capital/Financing Update
2026
May 26
Major Shareholding Notification
2026
May 8
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 21